
First-in-humans study introduces next generation cell therapy
Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or “smart” stem cells can improve heart health for people suffering from heart failure. This is the first application in patients of lineage-guided stem cells for targeted regeneration of a failing organ, paving the way to development of next generation regenerative medicine solutions. Dennis Douda has this report. [TRT 2:05]
Results of the clinical trial appear online of the Journal of the American College of Cardiology
Click here news release
http://www.youtube.com/watch?v=vumB_FW_fTA
[Video and animation are available in the downloads. Reporter pkgs. can be edited into vo/sots and incorporated into your local reporting.]
ROCHESTER, Minn. — Heart failure is a potentially urgent health concern for young adults with congenital heart disease (ACHD) that is often overlooked and undertreated, ...
Mayo Clinic doctors are using innovation to improve the lives of people who suffer from congestive heart failure and other chronic heart conditions. The Organ ...
Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have found a ...